| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |